参考文献/References:
[1] Inagaki-Ohara K, Kondo T, Ito M,et al. SOCS, inflammation, and cancer[J]. JAKSTAT, 2013, 2(3): e24053.
[/br][2] Royer MC, Zhang H, Fan CY, et al. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: an analysis of hOGG1 loss of heterozygosity[J]. Arch Otolaryngol Head Neck Surg, 2010, 136(3): 240-242.
[/br][3] Allavena P,Germano G,Marchesi F,et al.Chemokines in cancer related inflammation[J]. Exp Cell Res, 2011, 317(5): 664-673.
[/br][4] Lumachi F, Basso SM, Orlando R. Cytokines, thyroid diseases and thyroid cancer[J]. Cytokine, 2010, 50(3): 229-233.
[/br][5] Popawska-Kita A, Szelachowska M, Modzelewska A, et al. Endothelial dysfunction in Graves' disease[J]. Adv Med Sci, 2013, 58(1): 31-37.
[/br][6] Ruggeri RM, Villari D, Simone A, et al. Co-expression of interleukin-6(IL-6)and interleukin-6 receptor(IL-6R)in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor[J]. J Endocrinol Invest, 2002, 25(11): 959-966.
[/br][7] Linkov F, Ferris RL, Yurkovetsky Z, et al. Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases[J]. Proteomics Clin Appl, 2008, 2(12): 1575-1585.
[/br][8] Çil E, Kumral A, Kanmaz-Özer M, et al. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer[J]. Mol Biol Rep, 2014, 41(5): 3091-3097.
[/br][9] Pacifico F, Crescenzi E, Mellone S, et al. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a[J]. J Clin Endocrinol Metab, 2010, 95(3): 1421-1430.
[/br][10] Bauerle KT, Schweppe RE, Haugen BR. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis and invasion[J]. Mol Cancer, 2010, 9: 117.
[/br][11] Meng Z, Mitsutake N, Nakashima M, et al. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cells[J]. Endocrinology, 2008,149(11): 5357-5365.
[/br][12] Mitsiades CS, Poulaki V, Mitsiades N. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer[J]. J Endocrinol, 2003, 178(2): 205-216.
[/br][13] Mitsiades N, Poulaki V, Mitsiades CS, et al. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases[J]. Trends Endocrinol Metab, 2001, 12(9): 384-390.
[/br][14] 张海燕, 邓娓娓, 都镇先, 等. γ-干扰素对TRAIL诱导人甲状腺癌细胞凋亡影响的研究[J]. 中国肿瘤防治杂志, 2009, 16(6): 406-409.
[/br][15] Wang SH, Mezosi E, Wolf JM, et al. IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression[J]. Oncogene, 2004, 23(4): 928-935.
[/br][16] Tanaka K, Kurebayashi J, Sohda M, et al. The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence[J]. Thyroid, 2009, 19(1): 21-25.
[/br][17] Buitrago D, Keutgen XM, Crowley M, et al. Intercellular adhesion molecule-1(ICAM-1)is upregulated in aggressive papillary thyroid carcinoma[J]. Ann Surg Oncol, 2012, 19(3): 973-980.
[/br][18] Marecko I, Cvejic D, Selemetjev S, et al. Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration[J]. Croat Med J, 2014, 55(2): 128-137.
[/br][19] Lima PC, Moura Neto A, Tambascia MA, et al. Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases[J]. ISRN Endocrinol, 2013, 2013: 673146.
[/br][20] Jankovic B, Le KT, Hershman JM.Clinical review:Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?[J]. J Clin Endocrinol Metab, 2013, 98(2): 474-482.
[/br][21] 刘友忠, 于洋, 赵翠, 等. 甲状腺乳头状癌合并桥本甲状腺炎的临床生物学特性分析[J]. 中华普通外科杂志, 2013, 28(4): 256-258.
[/br][22] Rhoden KJ, Unger K, Salvatore G, et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma[J]. J Clin Endocrinol Metab, 2006, 91(6): 2414-2423.
[/br][23] Cantalamessa L, Baldini M, Orsatti A, et al. Thyroid nodules in Graves disease and the risk of thyroid carcinoma[J]. Arch Intern Med, 1999, 159(15): 1705-1708.
[/br][24] Gul K, Di Ri Koc A, Ki Yak G, et al. Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis[J]. Minerva Endocrinol, 2009, 34(4): 281-318.
[/br][25] Pascual Corrales E, Príncipe RM, Laguna Muro S, et al. Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter[J]. Endocrinol Nutr, 2012, 59(3): 169-173.
相似文献/References:
[1]张红 章向成 朱大龙.炎性反应与糖尿病肾病[J].国际内分泌代谢杂志,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
Zhang Hong*,Zhang Xiangcheng,Zhu Dalong..Role of inflammation in diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(06):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
[2]刘琦,周赛君,孟振兴,等.P2X7受体与糖尿病视网膜病变[J].国际内分泌代谢杂志,2015,(02):127.[doi:10.3760/cma.j.issn.1673-4157.2015.02.015]
Liu Qi,Zhou Saijun,Meng Zhenxing,et al.P2X7 receptor and diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2015,(06):127.[doi:10.3760/cma.j.issn.1673-4157.2015.02.015]
[3]邵滢,王秋月.MiRNA-150与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
Shao Ying,Wang Qiuyue..MiRNA-150 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(06):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
[4]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(06):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[5]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(06):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[6]邵金双,邸阜生.网膜素抗炎作用及与代谢相关疾病的关系[J].国际内分泌代谢杂志,2014,(01):29.[doi:10.3760/cma.j.issn.1673-4157.2014.01.008]
Shao Jinshuang*,Di Fusheng ..Anti-inflammatory effect of omentin and its relationship with metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(06):29.[doi:10.3760/cma.j.issn.1673-4157.2014.01.008]
[7]冯红,徐勇,苟芳,等.炎症小体与糖尿病并发症[J].国际内分泌代谢杂志,2014,(01):46.[doi:10.3760/cma.j.issn.1673-4157.2014.01.013]
Feng Hong,Xu Yong,Gou Fang,et al.Inflammasome and diabetic complications[J].International Journal of Endocrinology and Metabolism,2014,(06):46.[doi:10.3760/cma.j.issn.1673-4157.2014.01.013]
[8]王兴纯,曲伸.GLP-1及其受体激动剂与炎性反应及氧化应激[J].国际内分泌代谢杂志,2014,(04):263.[doi:10.3760/cma.j.issn.1673-4157.2014.04.014]
Wang Xingchun,Qu Shen..Association of GLP-1 and its receptor agonist with inflammation and oxidative stress[J].International Journal of Endocrinology and Metabolism,2014,(06):263.[doi:10.3760/cma.j.issn.1673-4157.2014.04.014]
[9]王丙玉 孙建平 段薇.Th1、Th2、Th17相关细胞因子在甲状腺相关眼病中的
作用机制[J].国际内分泌代谢杂志,2018,38(06):394.[doi:10.3760/cma.j.issn.1673-4157.2018.06.008]
Wang Bingyu,Sun Jianping,Duan Wei.Mechanism of Th1, Th2, Th17 related cytokines in thyroid-associated ophthalmopathy[J].International Journal of Endocrinology and Metabolism,2018,38(06):394.[doi:10.3760/cma.j.issn.1673-4157.2018.06.008]
[10]王中京 邓艾平 李居怡 徐子辉 吕晓玉 张旭艳 付秀丽 李亚蓉 宋春宇.细胞因子与糖尿病足血管发生的相关性研究[J].国际内分泌代谢杂志,2019,39(02):120.[doi:10.3760/cma.j.issn.1673-4157.2019.02.012]
Wang Zhongjing,Deng Aiping,Li Juyi,et al.Study on the correlation of cytokines and the angiogenesis of diabetic foot[J].International Journal of Endocrinology and Metabolism,2019,39(06):120.[doi:10.3760/cma.j.issn.1673-4157.2019.02.012]